Patents by Inventor Ian Sarembock

Ian Sarembock has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY RESPONSE
    Publication number: 20070265440
    Abstract: Compositions for oral administration of compounds having A2A adenosine receptor antagonist activity are provided. These compositions are useful for treatment of inflammatory conditions.
    Type: Application
    Filed: April 24, 2007
    Publication date: November 15, 2007
    Inventors: Joel Linden, Gail Sullivan, Ian Sarembock, Timothy MacDonald, Mark Okusa, Irving Kron, W. Scheld
  • Method for treating restenosis with A2A adenosine receptor agonists
    Patent number: 6448235
    Abstract: Agonists of A2A adenosine receptors in combination with rolipram, its derivatives or other Type IV phosphodiesterase (PDE) inhibitors are effective for the treatment of restenosis.
    Type: Grant
    Filed: April 4, 2000
    Date of Patent: September 10, 2002
    Assignee: University of Virginia Patent Foundation
    Inventors: Joel M. Linden, Gail W. Sullivan, Ian Sarembock, W. Michael Sheld
  • METHOD FOR TREATING RESTENOSIS WITH A2A ADENOSINE RECEPTOR AGONISTS
    Publication number: 20020082240
    Abstract: Agonists of A2A adenosine receptors in combination with rolipram, its derivatives or other Type IV phosphodiesterase (PDE) inhibitors are effective for the treatment of inflammatory diseases.
    Type: Application
    Filed: April 4, 2000
    Publication date: June 27, 2002
    Inventors: Joel M Linden, Gail W Sullivan, Ian Sarembock, W Michael Sheld